The US and Canada have healthcare, life science and medical device industries that are complex and interconnected.
On March 6, President Donald Trump instituted a 25 percent ad valorem rate of duty on goods imported from Canada under the International Emergency Economic Powers Act.[1] The tariffs will not be implemented on goods that comply with the United States-MexicoCanada Agreement until April 2.[2] In turn, Canada has announced a $155 billion tariff package on the US.[3]
Download the full Law360 article, "Mitigating Tariff Risks For Healthcare In US And Canada."
Publication
On 15 July 2025 the Financial Conduct Authority (FCA) published its final rules in relation to reform of the UK prospectus regime (see PS 25/9: New rules for the public offers and admissions to trading regime), largely adopting the approach proposed in its consultation last summer. This is the latest step in the process of reforming the UK’s capital markets, following on from the overhaul of the UK Listing Rules (UKLR) in 2024.
Publication
On 10 July 2025, the UK government published its Review of Electricity Market Arrangements (REMA) Summer Update, which sets out the long-awaited outcome of the REMA programme and next steps towards a decarbonised, affordable, secure and efficient electricity market.
Publication
The process for closing out derivatives is a technical and complex one, and any step along the way can be a source of disputes, and an opportunity to challenge the counterparty’s actions, if formalities are not complied with.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025